Predisposition or side effect of the duration: the reactivity of the HPA-axis under psychosocial stress in panic disorder

International Journal of Psychophysiology

Volumn 107, Issue , 2016, Pages 9-15

  Wintermann, Gloria Beatrice ^a   Kirschbaum, Clemens ^b   Petrowski, Katja ^a,c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Duration; HPA axis; Onset; Panic disorder; Salivary cortisol; TSST

Indexed keywords

HYDROCORTISONE; ORAL CONTRACEPTIVE AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; DSM-IV; FEMALE; HEALTH STATUS; HEART RATE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL STRESS; OUTCOME ASSESSMENT; PANIC; RISK FACTOR; SEX DIFFERENCE; SMOKING; STRESS ASSESSMENT; STRUCTURED INTERVIEW; TRIER SOCIAL STRESS TEST; ANALYSIS OF VARIANCE; COMPLICATION; ETIOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; RETROSPECTIVE STUDY; SALIVA; TIME FACTOR; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SALIVA; STRESS, PSYCHOLOGICAL; TIME FACTORS; YOUNG ADULT;

EID: 84977117376     PISSN: 01678760     EISSN: 18727697     Source Type: Journal    
DOI: 10.1016/j.ijpsycho.2016.06.008     Document Type: Article

References (57)

1. Abelson, J.L., Curtis, G.C., Hypothalamic–pituitary–adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol. Arch. Gen. Psychiatry 53 (1996), 323–331.
2. Abelson, J.L., Khan, S., Liberzon, I., Young, E.A., HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety 24 (2007), 66–76.
3. APA, Diagnostic and Statistical Manual of Mental Disorders. fourth ed., 2000, American Psychiatric Association, Washington, DC Text Revision (DSM-IV-TR).
4. Bandelow, B., Panik- und Agoraphobieskala (PAS). 1997, Hogrefe, Göttingen.
5. Bandelow, B., Michaelis, S., Epidemiology of anxiety disorders in the 21st century. Dialogues Clin. Neurosci. 17 (2015), 327–335.
6. Bandelow, B., Wedekind, D., Pauls, J., et al. Salivary cortisol in panic attacks. Am. J. Psychiatry 157 (2000), 454–456.
7. Batelaan, N.M., de Graaf, R., Penninx, B.W., et al. The 2-year prognosis of panic episodes in the general population. Psychol. Med. 40 (2010), 147–157.
8. Beck, A.T., Ward, C.H., Mendelson, M., et al. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961), 561–571.
9. Booij, S.H., Bouma, E.M., de Jonge, P., et al. Chronicity of depressive problems and the cortisol response to psychosocial stress in adolescents: the TRAILS study. Psychoneuroendocrinology 38 (2013), 659–666.
10. Christiana, J.M., Gilman, S.E., Guardino, M., et al. Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychol. Med. 30 (2000), 693–703.
11. Dressendörfer, R.A., Kirschbaum, C., Rohde, W., Synthesis of a cortisol–biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J. Steroid Biochem. 43 (1992), 683–692.
12. Erhardt, A., Ising, M., Unschuld, P.G., et al. Regulation of the hypothalamic–pituitary–adrenocortical system in patients with panic disorder. Neuropsychopharmacology 31 (2006), 2515–2522.
13. Finitsis, D.J., Cruess, D.G., Perez, G.K., et al. Anxiety chronicity and psychiatric comorbidity: influences on salivary alpha-amylase in a diagnostically heterogeneous sample of outpatients with anxiety disorders. J. Depress Anxiety, 2, 2013, 1000135.
14. Fries, E., Hesse, J., Hellhammer, J., Hellhammer, D.H., A new view on hypocortisolism. Psychoneuroendocrinology 30 (2005), 1010–1016.
15. Goodwin, R.D., Faravelli, C., Rosi, S., et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur. Neuropsychopharmacol. 15 (2005), 435–443.
16. Hautzinger, M., Bailer, M., Worall, H., Keller, F., Beck-Depressions-Inventar (BDI). 1994, Huber, Bern.
17. Hek, K., Direk, N., Newson, R.S., et al. Anxiety disorders and salivary cortisol levels in older adults: a population-based study. Psychoneuroendocrinology 38 (2013), 300–305.
18. Ising, M., Horstmann, S., Kloiber, S., et al. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression — a potential biomarker?. Biol. Psychiatry 62 (2007), 47–54.
19. Jakuszkowiak-Wojten, K., Landowski, J., Wiglusz, M.S., et al. Cortisol as an indicator of hypothalmic–pituitary–adrenal axis dysregulation in patients with panic disorder: a literature review. Psychiatr. Danub. 27:Suppl. 1 (2015), S445–S451.
20. Jezova, D., Makatsori, A., Duncko, R., et al. High trait anxiety in healthy subjects is associated with low neuroendocrine activity during psychosocial stress. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004), 1331–1336.
21. Jezova, D., Vigas, M., Hlavacova, N., Kukumberg, P., Attenuated neuroendocrine response to hypoglycemic stress in patients with panic disorder. Neuroendocrinology 92 (2010), 112–119.
22. Kessler, R.C., Chiu, W.T., Jin, R., et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 63 (2006), 415–424.
23. Kirschbaum, C., Wust, S., Hellhammer, D., Consistent sex differences in cortisol responses to psychological stress. Psychosom. Med. 54 (1992), 648–657.
24. Kirschbaum, C., Pirke, K.M., Hellhammer, D.H., The ‘Trier Social Stress Test’—a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 (1993), 76–81.
25. Kirschbaum, C., Pirke, K.M., Hellhammer, D.H., Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication. Psychoneuroendocrinology 20 (1995), 509–514.
26. Kirschbaum, C., Kudielka, B.M., Gaab, J., et al. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus–pituitary–adrenal axis. Psychosom. Med. 61 (1999), 154–162.
27. Klauke, B., Deckert, J., Reif, A., et al. Life events in panic disorder-an update on “candidate stressors”. Depress Anxiety 27 (2010), 716–730.
28. Kudielka, B.M., Kirschbaum, C., Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 69 (2005), 113–132.
29. Kudielka, B.M., Buske-Kirschbaum, A., Hellhammer, D.H., Kirschbaum, C., HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. Psychoneuroendocrinology 29 (2004), 83–98.
30. Kudielka, B.M., Hellhammer, D.H., Kirschbaum, C., Ten years of research with the Trier Social Stress Test—revisited. Harmon-Jones, E., Winkielman, P., (eds.) Social Neuroscience: Integrating Biological and Psychological Explanations of Social Behavior, 2007, Guilford Press, New York, NY, 56–83.
31. Laux, L., Glanzmann, P., Schaffner, P., Spielberger, C.D., Das State-Trait-Angstinventar. 1981, Theoretische Grundlagen und Handanweisung. Weinheim, Beltz Testgesellschaft.
32. Manenschijn, L., Spijker, A.T., Koper, J.W., et al. Long-term cortisol in bipolar disorder: associations with age of onset and psychiatric co-morbidity. Psychoneuroendocrinology 37 (2012), 1960–1968.
33. McEwen, B.S., Stress, adaptation, and disease. Allostasis and allostatic load. Ann. N. Y. Acad. Sci. 840 (1998), 33–44.
34. McEwen, B.S., Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. N. Y. Acad. Sci. 1032 (2004), 1–7.
35. Meuret, A.E., Trueba, A.F., Abelson, J.L., et al. High cortisol awakening response and cortisol levels moderate exposure-based psychotherapy success. Psychoneuroendocrinology 51 (2015), 331–340.
36. Mlynarik, M., Makatsori, A., Dicko, I., et al. Postural changes associated with public speech tests lead to mild and selective activation of stress hormone release. J. Physiol. Pharmacol. 58 (2007), 95–103.
37. Petrowski, K., Herold, U., Joraschky, P., et al. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses. Psychoneuroendocrinology 35 (2010), 414–421.
38. Petrowski, K., Wintermann, G.B., Kirschbaum, C., Bornstein, S.R., Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder. Psychoneuroendocrinology 37 (2012), 1199–1208.
39. Petrowski, K., Wintermann, G.B., Schaarschmidt, M., et al. Blunted salivary and plasma cortisol response in patients with panic disorder under psychosocial stress. Int. J. Psychophysiol. 88 (2013), 35–39.
40. Pruessner, J.C., Kirschbaum, C., Meinlschmid, G., Hellhammer, D.H., Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (2003), 916–931.
41. Radespiel-Tröger, M., Rauh, R., Mahlke, C., Gottschalk, T., Mück-Weymann, M., Agreement of two different methods for measurement of heart rate variability. Clin. Auton. Res. 13 (2003), 99–102.
42. Rohleder, N., Kirschbaum, C., The hypothalamic–pituitary–adrenal (HPA) axis in habitual smokers. Int. J. Psychophysiol. 59 (2006), 236–243.
43. Roy-Byrne, P.P., Stang, P., Wittchen, H.U., et al. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br. J. Psychiatry 176 (2000), 229–235.
44. Schommer, N.C., Hellhammer, D.H., Kirschbaum, C., Dissociation between reactivity of the hypothalamus–pituitary–adrenal axis and the sympathetic–adrenal–medullary system to repeated psychosocial stress. Psychosom. Med. 65 (2003), 450–460.
45. Schreiber, W., Lauer, C.J., Krumrey, K., et al. Dysregulation of the hypothalamic–pituitary–adrenocortical system in panic disorder. Neuropsychopharmacology 15 (1996), 7–15.
46. Seeman, T.E., Singer, B., Wilkinson, C.W., McEwen, B., Gender differences in age-related changes in HPA axis reactivity. Psychoneuroendocrinology 26 (2001), 225–240.
47. Sheikh, J.I., Leskin, G.A., Klein, D.F., Gender differences in panic disorder: findings from the National Comorbidity Survey. Am. J. Psychiatry 159 (2002), 55–58.
48. Siegmund, A., Koster, L., Meves, A.M., et al. Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia. J. Psychiatr. Res. 45 (2011), 339–346.
49. Spielberger, C.D., Gorsuch, R.L., Lushene, R.E., Manual for the State-Trait Anxiety Inventory. 1970, Consulting Psychologists Press, Palo Alto, Ca.
50. Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., SCID: User's Guide for the Structured Clinical Interview for DSM-III-R. 1990, American Psychiatric Press, Washington, DC.
51. van Duinen, M.A., Schruers, K.R., Jaegers, E., et al. Salivary cortisol in panic: are males more vulnerable?. Neuro Endocrinol. Lett. 25 (2004), 386–390.
52. Wagner, K.D., Berenson, A.B., Norplant-associated major depression and panic disorder. J. Clin. Psychiatry 55 (1994), 478–480.
53. Watanabe, A., Nakao, K., Tokuyama, M., Takeda, M., Prediction of first episode of panic attack among white-collar workers. Psychiatry Clin. Neurosci. 59 (2005), 119–126.
54. Weber, H., Richter, J., Straube, B., Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing. Mol. Psychiatry 21 (2016), 813–822.
55. Westberg, P., Modigh, K., Lisjo, P., Eriksson, E., Higher postdexamethasone serum cortisol levels in agoraphobic than in nonagoraphobic panic disorder patients. Biol. Psychiatry 30 (1991), 247–256.
56. Wittchen, H.-U., Zaudig, M., Fydrich, T., Strukturiertes Klinisches Interview für DSM-IV. 1997, Hogrefe, Göttingen.
57. Yonkers, K.A., Zlotnick, C., Allsworth, J., et al. Is the course of panic disorder the same in women and men?. Am. J. Psychiatry 155 (1998), 596–602.